Fischer introduces next-generation digital mammography system
The SenoScan2 slot scanning digital mammography (SSDM) system from Fischer Imaging is being introduced at the RSNA meeting. Fischer designs, manufactures, and markets medical imaging systems for screening and diagnosis.
The SenoScan2 slot scanning digital mammography (SSDM) system from Fischer Imaging is being introduced at the RSNA meeting. Fischer designs, manufactures, and markets medical imaging systems for screening and diagnosis.
The system mixes high image resolution and reduced radiation dose, while virtually eliminating motion artifacts, according to the company. Fischer calls it the next generation of slot scanning technology and claims SenoScan2 is the only digital mammography unit to offer both 50- and 25-micron native diagnostic resolution.
SenoScan2 will be included in a three-year global agreement signed last month with Philips Medical Systems. Under terms of the agreement, Philips will sell, service, and support a specialized version of Fischer's digital mammography system integrated with Philips' image processing and user interface.
"The SenoScan2 enables users to fully maximize image quality with customizable workflow and image management capabilities in a series of robust workstations that will scale to their needs," said Harris Ravine, president and CEO of Fischer. "The partnership with Philips will dramatically expand access to powerful end-to-end digital mammography solutions."
Fischer's slot scanning technology uses a tightly collimated x-ray beam that scans in precise alignment with a narrow slotted image receptor. The design essentially eliminates the negative effects of scatter radiation without requiring the use of a grid. The result is sharp, high-resolution images with up to a 60% reduction in radiation dose, according to the company.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
February 28th 2025In addition to contrast-enhanced mammography (CEM) demonstrating over a 90 percent detection rate for multifocal masses, researchers found that no significant difference between histological measurements and CEM, according to study findings presented at the European Congress of Radiology.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.
